How Pathways May Play Into How Glioblastoma Research Is Conducted
by Rob Sutter
After looking at stories related to glioblastoma research recently, I couldn't help but place my focus on one report in particular. It was a study that was done by the individuals of the Ohio State University Comprehensive Cancer Center and it seems like new information has come to the surface. Basically, the work was able to identify a new metabolic pathway in order to drive the growth of cancer cells. For more information, I would recommend that you continue to read about this specific study.
You may be interested to learn about this condition beforehand, if you don't know much about it already. The report in question talked about this, saying that the National Cancer Institute estimated that 23,130 people in America would be diagnosed in 2013. If you're looking particularly at glioma, it makes up 15% of growth cases, which is actually pretty substantial when you consider that more than 120 types exist. Work has to be done on the matter and you can be certain that there is.
The story in question was covered by News-Medical.net and it seems like quite a story that could help in the way of <a href="https://www.facebook.com/VoicesAgainstBrainCancer/">glioblastoma research</a> for a multitude of reasons. First of all, it could aid in the seeking of cures for those with the most common type of tumor known. Therapies are built based on the information that is discovered. When it comes to such details, I don't think that organizations the likes of Voices against Brain Cancer could be able to turn away.
What I am sure many individuals aren't aware of is the idea that glioma has four variations to consider. With proneural, neutral, classic, and <a href="http://news.yahoo.com/roche-drug-approved-japan-treatment-brain-cancer-053905868.html/">mesenchymal</a> types, the last option is the one that stands out. For those who don't know, this is seen as the most aggressive subtype to talk about, which can ultimately lead into poorer prognoses amongst patients. However, with ALDH1A3 having a greater presence with his type, the value in terms of therapy building is comparatively higher than with the others.
As you can tell, work is being done to help on this matter and I don't think that anyone can agree with the potential that this houses. Will it provide great results for those invested in glioblastoma research? I believe that it can but I suppose it depends on how well the research in question is done. If this is the case, then I am of the opinion that matters will be taken care of and that, before long, the therapies in place will be changed for the better.
Visit <a href="http://www.voicesagainstbraincancer.org/">Voices Against Brain Cancer</a> if you are seeking more information about <a href="http://www.voicesagainstbraincancer.org/about-us/garylichtenstein/">glioblastoma</a>.. This article, <a href="http://www.uberarticles.com/home.php?id=1858141&p=56131">How Pathways May Play Into How Glioblastoma Research Is Conducted</a> has free reprint rights.
---------------------------------------------------
You are receiving this because you signed up for it on 2011-11-27 from IP 188.29.196.69
To fine-tune your selection of which articles to receive, just login here:
http://www.uniquearticlewizard.com/bloggers/
using your username:
To unsubscribe please use the following link:
http://www.uniquearticlewizard.com/unsubscribe.php?mail=nightcabcontroller.sante1@blogger.com&code=f1f5baef192407461ee7ffe7468a92d2
---------------------------------------------------
---------------------------------
New Unique Article!
Title: How Pathways May Play Into How Glioblastoma Research Is Conducted
Author: Rob Sutter
Email: seo@fishbat.com
Keywords: voices against brain cancer, brain cancer, glioblastoma, diease illness, family, health, brain cancer research
Word Count: 442
Category: Disease & Illness
---------------------------------
No comments:
Post a Comment